366 related articles for article (PubMed ID: 11927186)
21. Fluoxetine, 17-β estradiol or folic acid combined with intra-lateral septal infusions of neuropeptide Y produced antidepressant-like actions in ovariectomized rats forced to swim.
Molina-Hernández M; Téllez-Alcántara NP
Peptides; 2011 Dec; 32(12):2400-6. PubMed ID: 21971371
[TBL] [Abstract][Full Text] [Related]
22. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
23. [Antidepressant effect of microinjection of neuropeptide Y into the hippocampus is mediated by decreased expression of nitric oxide synthase].
Lian T; An SC
Sheng Li Xue Bao; 2010 Jun; 62(3):237-46. PubMed ID: 20571741
[TBL] [Abstract][Full Text] [Related]
24. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist.
Dumont Y; Cadieux A; Doods H; Pheng LH; Abounader R; Hamel E; Jacques D; Regoli D; Quirion R
Br J Pharmacol; 2000 Mar; 129(6):1075-88. PubMed ID: 10725255
[TBL] [Abstract][Full Text] [Related]
25. Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY(13-36) differentially affect different defensive behaviors in male, Long Evans rats.
Trent NL; Menard JL
Physiol Behav; 2013 Feb; 110-111():20-9. PubMed ID: 23274501
[TBL] [Abstract][Full Text] [Related]
26. Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
Taksande BG; Kotagale NR; Gawande DY; Bharne AP; Chopde CT; Kokare DM
Eur Neuropsychopharmacol; 2014 Jun; 24(6):955-63. PubMed ID: 24461723
[TBL] [Abstract][Full Text] [Related]
27. The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression.
Bjørnebekk A; Mathé AA; Brené S
Hippocampus; 2010 Jul; 20(7):820-8. PubMed ID: 19623606
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
[TBL] [Abstract][Full Text] [Related]
29. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
30. NMDA GluN2B receptors involved in the antidepressant effects of curcumin in the forced swim test.
Zhang L; Xu T; Wang S; Yu L; Liu D; Zhan R; Yu SY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():12-7. PubMed ID: 22960607
[TBL] [Abstract][Full Text] [Related]
31. The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice.
Karlsson RM; Choe JS; Cameron HA; Thorsell A; Crawley JN; Holmes A; Heilig M
Psychopharmacology (Berl); 2008 Jan; 195(4):547-57. PubMed ID: 17891380
[TBL] [Abstract][Full Text] [Related]
32. Tolerance to ethanol sedation and withdrawal hyper-excitability is mediated via neuropeptide Y Y1 and Y5 receptors.
Bhisikar SM; Kokare DM; Nakhate KT; Chopde CT; Subhedar NK
Life Sci; 2009 Nov; 85(21-22):765-72. PubMed ID: 19846044
[TBL] [Abstract][Full Text] [Related]
33. Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors.
Adewale AS; Macarthur H; Westfall TC
Neuropharmacology; 2007 May; 52(6):1396-402. PubMed ID: 17382974
[TBL] [Abstract][Full Text] [Related]
34. Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats.
Chen SH; Cheung RT
Neuroscience; 2003; 116(1):119-26. PubMed ID: 12535945
[TBL] [Abstract][Full Text] [Related]
35. Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.
Kask A; Schiöth HB; Harro J; Wikberg JE; Rägo L
Can J Physiol Pharmacol; 2000 Feb; 78(2):143-9. PubMed ID: 10737677
[TBL] [Abstract][Full Text] [Related]
36. The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors.
Hyland NP; Cox HM
Br J Pharmacol; 2005 Nov; 146(5):712-22. PubMed ID: 16100526
[TBL] [Abstract][Full Text] [Related]
37. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
38. [Involvement of hippocampal NMDA receptor and neuropeptide Y in depression induced by chronic unpredictable mild stress].
Yu L; An SC; Lian T
Sheng Li Xue Bao; 2010 Feb; 62(1):14-22. PubMed ID: 20179883
[TBL] [Abstract][Full Text] [Related]
39. Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Br J Pharmacol; 2003 Aug; 139(7):1360-8. PubMed ID: 12890716
[TBL] [Abstract][Full Text] [Related]
40. The Y1 receptor subtype mediates the cardiovascular changes evoked by NPY administered into the posterior hypothalamic nucleus of conscious rat.
Martin JR
Brain Res; 2004 Mar; 1002(1-2):11-20. PubMed ID: 14988028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
